Zimmer Biomet stock (US98956P1021): valuation metrics in focus after recent price move

Zimmer Biomet shares on the NYSE have been trading in the mid-80 USD range after a volatile start to 2026, putting the medical device group’s earnings multiple, dividend yield and recent trading range into sharper focus for investors.

Zimmer Biomet shares on the New York Stock Exchange under the ticker ZBH most recently closed at USD 86.72 on 06/04/2026, according to MarketBeat as of 06/04/2026, leaving the US-based medical device group trading below the midpoint of its 52-week range.

The company, headquartered in the United States with a primary listing on the NYSE, operates in the medical technology sector with a focus on musculoskeletal healthcare and orthopedics, as outlined in its own company description on Zimmer Biomet investor information as of 2026.

As of: 05.06.2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: Zimmer Biomet
• Sector/industry: Medical devices, musculoskeletal healthcare
• Headquarters/country: Warsaw, Indiana, United States
• Core markets: North America, Europe, selected international markets
• Key revenue drivers: Hip and knee implants, trauma and extremities, related surgical technologies
• Home exchange/listing venue: New York Stock Exchange (ZBH)
• Trading currency: USD

Zimmer Biomet: core business model

Zimmer Biomet focuses on musculoskeletal healthcare solutions, supplying orthopedic implants and related technologies that are used by hospitals and surgeons to treat joint disorders and injuries worldwide.

Valuation metrics and multiples for Zimmer Biomet

With the share price at USD 86.72 as of the close on 06/04/2026, Zimmer Biomet commanded a market capitalization of about USD 16.78 billion and traded at a price-to-earnings ratio of 22.52, based on data compiled by MarketBeat as of 06/04/2026.

The same data set shows a 52-week trading range from USD 79.12 to USD 108.29 and a dividend yield of 1.11 percent as of 06/04/2026, indicating that the stock has experienced notable price fluctuations over the past year within the medical technology peer group, according to MarketBeat figures published on 06/04/2026.

Conclusion

Zimmer Biomet’s share price in the mid-80 USD region and a current price-to-earnings ratio in the low 20s, based on MarketBeat data as of 06/04/2026, underscore how the market is valuing its orthopedic-focused business against recent earnings.

The 52-week range from roughly USD 79 to just over USD 108 and a dividend yield a little above 1 percent as of 06/04/2026 highlight both the stock’s volatility and its modest income component within the US medical device sector.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.